Last reviewed · How we verify

NCT04184908: XEROSTOMIA

Clinical Study New Gel for Xerostomia

Status unknown Phase 1 Last updated 5 December 2019
What this trial tests

Phase 1 trial testing gel xerostomia in XEROSTOMIA in 60 participants. Status unknown.

Timeline
1 October 2019
Primary endpoint
2 November 2019
31 December 2020

Quick facts

Lead sponsorUniversidad de Murcia
PhasePhase 1
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment60
Start date1 October 2019
Primary completion2 November 2019
Estimated completion31 December 2020
Sites2 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Murcia — full company profile →

Who can join

Adults 18 to 90, any sex, with XEROSTOMIA. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

At present, there is no single consensus protocol for the treatment of oral dryness, although the main objective is to improve the quality of life of patients. Current therapy for the control of xerostomia is based on the following measures: 1. General measures ; review and control of drugs,hydration and dietary advice: The main recommendations are found in the following scheme. 2. Saliva stimulants( Topics and sistemic )The option of using chewing stimuli by chewing gum with non-cariogenic sweeteners helps to improve symptoms. The investigators can also use gustatory stimuli, such as citric acid that is a potent stimulator of salivary secretion. Among the most commonly used pharmacological agents are: pilocarpine, bethanecol, civemiline 3. Saliva substitutes or artificial saliva. Saliva substitutes can provide a moisture retention layer in the oral mucosa and can be administered by liquids, spray, pills or gels. Topical treatments have few adverse effects and improve the quality of life of patients with xerostomia; In addition, they maintain oral health.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A Clinical Study on the Efficacy and Tolerability of a New Topical Gel and Toothpaste in Patients with Xerostomia: A Randomized Controlled Trial.
    López Jornet P, Hernandez L, Gomez García F, Galera Molero F, et al · · 2021 · cited 4× · PMID 34884343 · DOI 10.3390/jcm10235641

Verify or expand the search:

Other Universidad de Murcia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04184908.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing